Nicolas Rodondi, MD MAS, is Full Professor of Primary Care and Internal Medicine, Director of the Institute of Primary Health Care (BIHAM), University of Bern and Head of Ambulatory Care, Clinic of General Internal Medicine, Inselspital, Switzerland. Continuously supported by grants from the Swiss National Science Foundation (SNSF), EU multicenter grants, and others, he has conducted several studies designed to identify the best strategies for preventing cardiovascular disease, lowering potential overdiagnosis and overuse of therapies in the elderly. He has authored and co-authored more than 400 original articles and reviews published in journals including the NEJM, JAMA, Lancet Annals of Internal Medicine and Circulation. He has also set up large studies, including the international Thyroid Studies Collaboration (TSC), with its 28 prospective cohorts on 5 continents (156’718 participants) (https://www.thyroid-studies.org). He was Switzerland’s PI for the TRUST trial, the largest trial on thyroid hormone replacement; TRUST was funded by EU FP7-Health-2011. He is the Coordinator (“EU PI”) of the OPERAM project to address polypharmacy in the multimorbid elderly, which was funded by EU HORIZON 2020 (http://operam-2020.eu). He has a Master’s degree in Clinical Research (MAS) from the University of California, San Francisco at the Coordinating Centre of multiple large RCTs and cohort studies. He acts as an expert for several high impact factor journals and is a member of the Academic Board of the SNSF National Research Council.
